课题基金 / 基金详情

TREATMENT OF NEUROPATHIC PAIN

TREATMENT OF NEUROPATHIC PAIN
神经性疼痛的治疗
批准号:
6112491
负责人:
SRINIVASA N. RAJA
金额:
$25.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2000-07-31

项目摘要

项目成果

SRINIVASA N. RAJA的其他基金

相似基金

相关文献

中文摘要
翻译
这个项目的长远目标是更好地发展 治疗神经病理性疼痛的药理学策略。我们的 这里的具体目标是研究阿片类药物治疗的疗效 神经性疼痛的治疗。因为三环类抗抑郁药物治疗 阿米替林(如阿米替林)通常被认为是治疗的首选药物 对于神经性疼痛,我们希望将阿片类药物治疗与三环类药物进行比较 心理治疗。我们选择在这项研究中重点研究疱疹后遗症 神经痛(PHN)。我们这样做是因为PHN很常见,PHN提供了一个 在相同的疾病人群中,PHN已经在其他临床上进行了研究 研究试验和目前的治疗方法是不够的。虽然是三环 抗抑郁药已被用于治疗PHN,它们的效果 关于情感功能和认知功能的研究尚未系统 评估过了。在我们的初步研究中,使用阿片类药物进行开放标签试验 PHN的治疗取得了良好的效果。我们建议比较一下 安慰剂、阿米替林和一种长效吗啡制剂 关于止痛,以及对情感和认知功能的影响。 治疗的效果,包括并发症,将与 终生精神疾病和当前精神疾病共同发病率的衡量标准,特别是 抑郁症。持续疼痛3个月或以上的患者(N=120) 将参加这项随机、盲目、安慰剂对照的交叉试验 过度学习。在完成无药物基线阶段后,每个患者 将接受包括安慰剂在内的3个为期4周的疗程, 阿米替林和吗啡。患者将被随机分配到一组 三种疗法的6种可能顺序中的一种。这个 治疗期之前将有一个药物洗脱期和一个时期 使滴定达到最大效果。结果衡量标准将评估疼痛 强度,疼痛缓解,痛觉过敏的心理物理指标, 认知、情绪和功能的干扰/损害。精神科 筛查将在整个研究过程中进行,使用结构化诊断 乐器。这些测量将在第一种药物之前进行 在这三个治疗期的每一个期间。这项研究将 有助于我们对三环和阿片类药物治疗的理解 神经性疼痛的治疗。此外,这项研究将有助于推动 临床试验研究领域,因为它适用于疼痛研究。 从这项研究中得出的经验教训将导致进一步的比较研究 这些药物将提供病人护理,并揭示 神经病理性疼痛状态的病理生理基础。
英文摘要
The long range objective of this project is to develop better pharmacological strategies for treatment of neuropathic pain. Our specific goal here is to study the efficacy of opioid therapy for treatment of neuropathic pain. Because tricyclic antidepressant therapy (e.g. amitriptyline) is often considered the drug of choice for treatment of neuropathic pain, we wish to compare opioid therapy with tricyclic therapy. We have elected to focus in this study on post-herpetic neuralgia (PHN). We do this because PHN is common, PHN provides a homogeneous disease population, PHN has been studied in other clinical research trials, and present therapies are inadequate. Although tricyclic antidepressants have been used for the treatment of PHN, their effects on affective and cognitive functions have not been systematically assessed. In our preliminary studies open-label trials with opiates for treatment of PHN have yielded favorable outcomes. We propose to compare placebo, amitriptyline, and a long-acting preparation of morphine with regard to pain relief, and effects on affective and cognitive function. Effects of treatment, including complications, will be correlated with measures of lifetime and current psychiatric co-morbidity, particularly depression. Patients (N=120) with persistent pain for 3 months or longer will be enrolled in this randomized, blinded, placebo-controlled, cross- over study. After completing a drug-free baseline period, each patient will undergo 3 four-week treatment periods consisting of a placebo, amitriptyline, and morphine. Patients will be randomly assigned to one of the 6 possible orders in which the three treatments can be given. The treatment periods will be preceded by a drug wash-out period and a period for titration to maximal effect. The outcome measures will assess pain intensity, pain relief, psychophysical measures of hyperalgesia, cognition, mood and interference/impairment of function. Psychiatric screening will occur throughout the study, using structured diagnostic instruments. These measurements will be made before the first drug period, and during each of the three treatment periods. This study will contribute to our understanding of tricyclic and opioid therapy for treatment of neuropathic pain. Moreover, this study will help advance the field of clinical trials research as it applies to the study of pain. Lessons derived from this study will lead to further comparative studies of drugs that will impart patient care and cast light on the pathophysiological basis of neuropathic pain states.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Post-Amp Pain
  • 批准号:
    7044588
  • 项目类别:
  • 资助金额:
    $0.49万
  • 财政年份:
    2003
  • 负责人:
    SRINIVASA N. RAJA
  • 依托单位:
LONG ACTING OPIOIDS IN AMPUTATION PAIN MANAGEMENT
  • 批准号:
    6354092
  • 项目类别:
  • 资助金额:
    $26.21万
  • 财政年份:
    2000
  • 负责人:
    SRINIVASA N. RAJA
  • 依托单位:
LONG ACTING OPIOIDS IN AMPUTATION PAIN MANAGEMENT
  • 批准号:
    6202103
  • 项目类别:
  • 资助金额:
    $26.21万
  • 财政年份:
    1999
  • 负责人:
    SRINIVASA N. RAJA
  • 依托单位:
LONG ACTING OPIOIDS IN AMPUTATION PAIN MANAGEMENT
  • 批准号:
    6108824
  • 项目类别:
  • 资助金额:
    $26.21万
  • 财政年份:
    1998
  • 负责人:
    SRINIVASA N. RAJA
  • 依托单位:
海外基金